Terms: = Gastric cancer AND SDHA, SDH2, 6389, ENSG00000073578, FP, P31040, SDHF AND Prognosis
28 results:
1. Clinical outcomes of Epstein-Barr virus (EBV)-associated metastatic and locally advanced unresectable gastric cancers (GCs) in patients receiving first-line fluoropyrimidine and platinum (FP) doublet chemotherapy.
Kim EJ; Chae H; Park YS; Ryu MH; Kim HD; Shin J; Park YS; Moon MS; Kang YK
Gastric Cancer; 2024 Jan; 27(1):146-154. PubMed ID: 38006567
[TBL] [Abstract] [Full Text] [Related]
2. MT1M regulates gastric cancer progression and stemness by modulating the Hedgehog pathway protein GLI1.
Li K; Sun S; Lu Y; Liang W; Xu X; Zhang H; Chang Z; Wang C; Gao Y; Chen L
Biochem Biophys Res Commun; 2023 Aug; 670():63-72. PubMed ID: 37276792
[TBL] [Abstract] [Full Text] [Related]
3. MTF1 has the potential as a diagnostic and prognostic marker for gastric cancer and is associated with good prognosis.
He J; Jiang X; Yu M; Wang P; Fu L; Zhang G; Cai H
Clin Transl Oncol; 2023 Nov; 25(11):3241-3251. PubMed ID: 37095424
[TBL] [Abstract] [Full Text] [Related]
4. Expression of AKRs superfamily and prognostic in human gastric cancer.
Zhou Y; Lin Y; Li W; Liu Q; Gong H; Li Y; Luo D
Medicine (Baltimore); 2023 Feb; 102(8):e33041. PubMed ID: 36827074
[TBL] [Abstract] [Full Text] [Related]
5. Overexpression of Copines-1 is associated with clinicopathological parameters and poor outcome in gastric cancer.
Yang J; Wang Y; Ge R; Jia X; Ge C; Cen Y; Pan D
J Clin Lab Anal; 2022 Nov; 36(11):. PubMed ID: 36310511
[TBL] [Abstract] [Full Text] [Related]
6. Patterns of Lymph Node Metastasis and Optimal Surgical Strategy in Small (≤20 mm) Gastroenteropancreatic Neuroendocrine Tumors.
Cai Y; Liu Z; Jiang L; Ma D; Zhou Z; Ju H; Zhu Y
Front Endocrinol (Lausanne); 2022; 13():871830. PubMed ID: 35937823
[TBL] [Abstract] [Full Text] [Related]
7. Clinical significance and prospective molecular mechanism of NUF2 in gastric cancer exploration: A comprehensive study based on the GeneChip, GEO, Oncomine, and TCGA databases.
Ge L; Sun Q; Xia L; Xu X
Medicine (Baltimore); 2022 Jul; 101(26):e29802. PubMed ID: 35777029
[TBL] [Abstract] [Full Text] [Related]
8. Thrombospondin-2 holds prognostic value and is associated with metastasis and the mismatch repair process in gastric cancer.
Chu XD; Lin ZB; Huang T; Ding H; Zhang YR; Zhao Z; Huangfu SC; Qiu SH; Guo YG; Chu XL; Pan JH; Pan YL
BMC Cancer; 2022 Mar; 22(1):250. PubMed ID: 35255858
[TBL] [Abstract] [Full Text] [Related]
9. Colorectal paragangliomas with immunohistochemical deficiency of succinate dehydrogenase subunit B.
Kimura N; Ishikawa M; Shigematsu K
Endocr J; 2022 May; 69(5):523-528. PubMed ID: 34853215
[TBL] [Abstract] [Full Text] [Related]
10. Toll-like receptor 3 is a potential prognosis marker and associated with immune infiltration in stomach adenocarcinoma.
Huang Z; He A; Wang J; Lu H; Xu X; Zhang R; Liao W; Feng Q; Wu L
Cancer Biomark; 2022; 34(1):77-93. PubMed ID: 34657879
[TBL] [Abstract] [Full Text] [Related]
11. Comprehensive Analysis of the Expression and prognosis for MCMs in Human gastric cancer.
Guo F; Kong WN; Feng YC; Lv J; Zhao G; Wu HL; Ai L; Zhou X; Cai XL; Sun W; Ma XM
Technol Cancer Res Treat; 2020; 19():1533033820970688. PubMed ID: 33167799
[TBL] [Abstract] [Full Text] [Related]
12. Comprehensive analysis of the expression of SLC30A family genes and prognosis in human gastric cancer.
Guo Y; He Y
Sci Rep; 2020 Oct; 10(1):18352. PubMed ID: 33110097
[TBL] [Abstract] [Full Text] [Related]
13. Performance of Gene Expression Profile Tests for prognosis in Patients With Localized Cutaneous Melanoma: A Systematic Review and Meta-analysis.
Marchetti MA; Coit DG; Dusza SW; Yu A; McLean L; Hu Y; Nanda JK; Matsoukas K; Mancebo SE; Bartlett EK
JAMA Dermatol; 2020 Sep; 156(9):953-962. PubMed ID: 32745161
[TBL] [Abstract] [Full Text] [Related]
14. FLAD1 is up-regulated in gastric cancer and is a potential prediction of prognosis.
Hu P; Pan Y; Wang C; Zhang W; Huang H; Wang J; Zhang N
Int J Med Sci; 2020; 17(12):1763-1772. PubMed ID: 32714079
[No Abstract] [Full Text] [Related]
15. Evaluation of MT Family Isoforms as Potential Biomarker for Predicting Progression and prognosis in gastric cancer.
Tong M; Lu W; Liu H; Wu J; Jiang M; Wang X; Hao J; Fan D
Biomed Res Int; 2019; 2019():2957821. PubMed ID: 31380415
[TBL] [Abstract] [Full Text] [Related]
16. gastric adenocarcinoma with enteroblastic differentiation should be differentiated from hepatoid adenocarcinoma: A study with emphasis on clear cells and clinicopathologic spectrum.
Kwon MJ; Byeon S; Kang SY; Kim KM
Pathol Res Pract; 2019 Sep; 215(9):152525. PubMed ID: 31301878
[TBL] [Abstract] [Full Text] [Related]
17. [Expression of succinate dehydrogenase subunit protein in succinate dehydrogenase-deficient gastrointestinal stromal tumors].
Zhang YJ; Cheng YH; Guo LX; Wang NQ; Liu H
Zhonghua Bing Li Xue Za Zhi; 2018 Apr; 47(4):252-257. PubMed ID: 29690663
[No Abstract] [Full Text] [Related]
18. Succinate dehydrogenase (SDH)-deficient neoplasia.
Gill AJ
Histopathology; 2018 Jan; 72(1):106-116. PubMed ID: 29239034
[TBL] [Abstract] [Full Text] [Related]
19. Loss of sdha expression identifies sdha mutations in succinate dehydrogenase-deficient gastrointestinal stromal tumors.
Dwight T; Benn DE; Clarkson A; Vilain R; Lipton L; Robinson BG; Clifton-Bligh RJ; Gill AJ
Am J Surg Pathol; 2013 Feb; 37(2):226-33. PubMed ID: 23060355
[TBL] [Abstract] [Full Text] [Related]
20. Succinate dehydrogenase (SDH) and mitochondrial driven neoplasia.
Gill AJ
Pathology; 2012 Jun; 44(4):285-92. PubMed ID: 22544211
[TBL] [Abstract] [Full Text] [Related]
[Next]
